Posted in Regulatory Travere claims first FDA OK in rare kidney disease FSGS April 14, 2026 Pharmaphorum Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare kidney disease FSGS. RegulatoryRare DiseaseRead full story